We partnered with Medwise.ai, an innovative technology company developing advanced AI solutions to enhance information searching and retrieval within the healthcare industry, to explore and expand the potential use cases for its advanced AI technology within the pharmaceutical industry.

Our approach involved gathering valuable insights from key stakeholders: 

• Pharmaceutical Industry Experts: We set up meetings with pharmaceutical companies to understand the unmet needs they experienced in information searching and retrieval. These discussions were helpful in gauging the potential of Medwise.ai’s technology to create value for pharmaceutical companies. 

• Use Case Analysis: We identified and explored specific prospective use cases for Medwise.ai's technology in clinical trial management, regulatory and medical affairs, and medical information. This involved an analysis of how AI solutions could streamline processes and improve decision-making in these areas.

 Through this approach, we were able to achieve two key outcomes: 

• Industry Insights: The meetings provided insights into the specific challenges faced by pharmaceutical companies, enabling Medwise.ai to fine-tune its technology and align it more closely with industry needs.

• Strategic Value Propositions: Through a collaborative design sprint, we helped Medwise.ai develop a robust value proposition that communicated the benefits of its technology. This value propositions will be instrumental in marketing the technology to potential pharma clients.

   

“It was a pleasure to work with Nexcea, they have extensive knowledge of the pharmaceutical industry and a great understanding of digital health technology. We wanted to explore applications of our AI technology in the life science industry. Nexcea identified and arranged meetings with multiple stakeholders from different companies in the industry, providing us with valuable information on pharma workflow, unmet needs, and how our AI could support current practices. The feedback was crucial in refining our product development." 

Keith Tsui, CEO, Medwise.ai